Australian Non-Invasive Prenatal Testing (NIPT) Market · GlobeNewswire Inc. Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Australia Non-Invasive Prenatal Testing (NIPT) Market: Focus on Technology, ...

(MENAFN- GlobeNewsWire - Nasdaq) Competition Synopsis for Key Market Players in the European Non-Invasive Prenatal Testing (NIPT) Market including F. Hoffmann-La Roche, Centogene, Yourgene Health and ...

The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at 16% by 2029. The high risk of chromosomal abnormalities with rising maternal age, the surge in the adoption of cell-free ...

Manchester, UK, 13 February 2025: Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, today announced the launch of IONA ® Care+, a fully ...

The adoption of NIPT has drastically reduced the need for risky invasive procedures like amniocentesis. In places like Switzerland, public health coverage of NIPT led to a 50% drop in amniocenteses.

Two of the world's largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Mexico Non-Invasive Prenatal Testing Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to ...

The U.S. Food and Drug Administration is warning women about a screening commonly performed during pregnancy. Non-invasive prenatal screening tests carry a risk of false results, the FDA said in a ...